These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628 [TBL] [Abstract][Full Text] [Related]
4. PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway. Li J; Lu X; Wei L; Ye D; Lin J; Tang X; Cui K; Yu S; Xu Y; Liang X Inflamm Res; 2022 Jan; 71(1):69-79. PubMed ID: 34773469 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway. Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831 [TBL] [Abstract][Full Text] [Related]
7. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome. Stalmans I Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858 [TBL] [Abstract][Full Text] [Related]